Mycobacterium Nucleic Acid Test Kit (PCR - Fluorescent Probe Method) Accurate and Fast Tuberculosis Screening Product It can fast identify the mycobacterium tuberculosis and non tuberculoaus mycobacteriosis, which is significant for determining therapeutic schedule as early as possible. Product Introduction Dual real time fluorescence PCR technology and TaqMan probe technology are used to achieve the identifying and test of mycobacterium tuberculosis (MTB) and non tuberculoaus mycobacteriosis (NTM). Currently, the kit is the unique PCR product in China that can fast identify CFDA. Product Advantages Fast Completing the whole test process within 3 hours Completing MTB and NTM test concurrently with one specimen in single test The LOD of MTB is up to 10 bacteria/reaction, and that of NTM is 100 bacteria/reaction The specificity is 98.9%, and detectable rate of positive MTB and negative MTB is 97.0% and 24.4% respectively Clinical Application ● Fast screening for suspected tuberculosis patient ● Auxiliary diagnosis for negative MTB ● Differential diagnosis for tuberculosis/NTM ● Auxiliary diagnosis for ex pulmonary tuberculosis ● MTB/NTM infection test of high risk population (people who closely contact with patient with smear positive, HIV patient, diabetes patient and patient who receives biological agent/immunosuppressor therapy)

Applicable Model ABI7700 and ABI7500 Fluorescent PCR Test System; FQD 96A Fluorescent Quantitative Polymerase Chain Reaction (PCR) Test System produced by Hangzhou Bioer Technology Co., Ltd.; Mastercycler ep realplex4 Real time Fluorescent Quantitative PCR instrument produced by Eppendorf Company. Clinical Verification Hospitals Beijing Geriatric Hospital Beijing Institute of Tuberculosis Control Mean Value (1,015 cases) Clinical Application Scheme NTM Microbial strain identifying for mycobacterium Combination drug therapy for microbial strain Fast diagnosis for multi-drug resistant tuberculosis...